News
Oktober 2, 2018
Bioventus Receives ANVISA Approval to Market DUROLANE in Brazil and Selects Pfizer as Exclusive Distribution Partner
HOOFDDORP, THE NETHERLANDS – October 2, 2018 – Bioventus, a global leader in orthobiologic solutions, has received approval from Agência Nacional de…
Juli 23, 2018
Bioventus Enters Into Definitive Agreement to Divest BMP Program
DURHAM, NC – July 23, 2018 – Bioventus, a global leader in orthobiologic solutions, has entered into a definitive agreement to divest its next…
März 5, 2018
Bioventus Launches DUROLANE in the US
DURHAM, NC - March 5, 2018 – Bioventus, a global leader in orthobiologic solutions, today launched DUROLANE, its single-injection, hyaluronic acid…
Februar 26, 2018
Bioventus to Co-Develop Next Generation Bone Allograft with LifeLink
DURHAM, NC – February 26, 2018 – Bioventus, a global leader in orthobiologic solutions, has entered into an agreement with LifeLink Tissue Bank, a…
Februar 12, 2018
Bioventus to Continue Distributing SUPARTZ FX Through 2028
DURHAM, NC - February 12, 2018 – Bioventus, a global leader in orthobiologic solutions, has entered into an extension of its agreement with Seikagaku…
Januar 31, 2018
Additional Strategic Funding for CartiHeal’s Ongoing AGILI-C™ IDE Clinical Study $2.5M boost by Bioventus brings latest investment round to $21M
KFAR SABA, ISRAEL and DURHAM, NC– January 31, 2018 - CartiHeal, developer of the proprietary Agili-C implant for the treatment of joint surface…
Januar 25, 2018
Bioventus Launches New Website for EXOGEN®
DURHAM, NC– January 25, 2018 – Bioventus, a global leader in orthobiologics, today has launched a new version of EXOGEN.com, the product website for…
September 13, 2017
Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN®
DURHAM, NC– September 13, 2017 – Bioventus, a global leader in orthobiologics, today announced the first patients have been enrolled in its BONES…
September 5, 2017
Bioventus Receives US FDA Approval for DUROLANE®
DURHAM, NC- September 5, 2017 – Bioventus, a global leader in orthobiologic solutions, today announced it has received US FDA approval for DUROLANE,…
August 7, 2017
Bioventus Names Greg Anglum SVP and CFO, Tony D’Adamio SVP and General Counsel
DURHAM, NC- August 7, 2017 – Bioventus®, a leader in orthobiologic solutions, today announced two changes to its executive leadership team. Greg…
News durchsuchen
Download-Bibliothek
Unternehmens- und Markenlogos
Herunterladen
Produktbilder
Herunterladen
